This article is more than 5 years old. Information may no longer be current.

Peripheral support catheter receives FDA clearance

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Medtronic announced that the FDA cleared for marketing an angled support catheter for use in procedures in the peripheral vascular system.

The catheter (TrailBlazer, Medtronic) is for use in endovascular procedures to treat patients with complex peripheral artery disease, the company stated in a press release.

The purpose of the catheter, which is available in sizes of 0.014 in, 0.018 in or 0.035 in, is to support guidewire during the process of accessing peripheral arteries, and to facilitate delivery of diagnostic agents and solutions, according to the release.

The catheter also has three radiopaque marker bands and a radiopaque shaft to enhance visibility, according to the release.